Wired PR News.com – In an effort to develop the first ever malaria vaccine, researchers are gearing up for the launch of a medical trial that will test a new vaccine on children in Africa. As reported by the Associated Press (AP), the trial will likely be the largest ever on the children of the continent, with 16,000 being tested.
Malaria is a disease spread by mosquitoes that is linked to the death of one million people each year. A vast majority of these individuals are African children who come into regular contact with the disease carrying insects.
According to the AP report, areas chosen for the trial include Ghana, Kenya, Tanzania, Malawi, and others. An estimated $400 million has so far been reportedly spent on research and preparation for the vaccine trial, with millions more pledged for helping with technological and medical upgrades.
Although researchers hope for a successful outcome, many have noted that the investments made will leave Africa in a better position to find vaccines for other serious conditions regardless of whether the vaccine proves effective.